A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM
Status:
Not yet recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the potential of JMT103 to treat hypercalcemia of
malignancy in patients with elevated serum calcium who do not respond to recent treatment
with intravenous bisphosphonates.